Navigation Links
Lilly Confirms Date and Conference Call for Third-Quarter 2009 Financial Results Announcement
Date:10/6/2009

INDIANAPOLIS, Oct. 6 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY) will announce its financial results for the third quarter of 2009 on Wednesday, October 21, 2009. Lilly will also conduct a conference call on that day with the investment community and media to further detail the company's financial performance.

The conference call will be held from 9:00 a.m. to 10:00 a.m. EDT. Investors, media and the general public can access a live webcast of the conference call through a link that will be posted on Lilly's website at www.lilly.com. The webcast of the conference call will be available for replay through November 20, 2009.

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers - through medicines and information - for some of the world's most urgent medical needs. Additional information about Lilly is available at www.lilly.com. F-LLY

(Logo: http://www.newscom.com/cgi-bin/prnh/20031219/LLYLOGO )

SOURCE Eli Lilly and Company


'/>"/>
SOURCE Eli Lilly and Company
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. NCQA and Lilly Launch Online Quality Improvement Guide to Help Reduce Health Care Disparities and Improve Patient Care
2. U.S. District Court Upholds Validity of Lillys Evista Patents Through 2014
3. Lilly Announces New U.S. Affiliate Leader
4. Cancer Advocacy Organization Confronts the Source of rBGH, Demands Pharmaceutical Giant Eli Lilly Stop Milking Cancer
5. Lilly Receives 100 Percent Rating on Corporate Equality Index Survey
6. Lilly Unveils Blueprint for Speeding Innovative Medicines to Patients
7. Lilly Names New Business Leaders
8. Chicago Bears Quarterback Jay Cutler, Eli Lilly and Company and the American Diabetes Association Team Up to Fund Diabetes Camp Scholarships Through "Touchdowns for Diabetes"
9. Lilly Named Best Company for Blacks in Technology
10. Lilly Reports on Outcome of Phase III Study of Arzoxifene
11. U.S. District Court Rules Against Lilly Regarding Gemzar Patent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/17/2017)... ... August 17, 2017 , ... When Amy Cowperthwait left the emergency ... with her a dream to make nursing education more relevant and prepare aspiring nurses ... were integrated into healthcare provider education. , “The human element was missing. ...
(Date:8/17/2017)... (PRWEB) , ... August 17, 2017 , ... ... for a period of three years for its residential drug and alcohol detox ... given to an organization and shows the organization’s substantial conformance to the CARF ...
(Date:8/17/2017)... ... August 17, 2017 , ... The line-up includes voices ... and effectively grow a dental practice in a competitive market environment where Corporate Dentistry ... that could just transform you and your practice.” says Daniel A. ‘Danny’ Bobrow, AIM ...
(Date:8/17/2017)... ... , ... Elemental LED, a leading U.S. based engineering and technology ... products were honored with Architectural SSL Product Innovation Awards (PIA) for the ... division, Diode LED, provides a wide variety of superior quality linear, task, and accent ...
(Date:8/17/2017)... ... August 17, 2017 , ... ... herself once more by being among Houston’s first plastic surgeons to offer boutique ... plastic surgery care without disrupting busy schedules and maintaining the utmost discretion in ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... 2017 Diplomat Pharmacy, Inc. (NYSE: DPLO), is ... residents. Naloxone is available without ... retail pharmacy, G-3320 Beecher Road. ... Drug Administration, is intended to block or reverse the ... loss of consciousness. The medication is often carried by ...
(Date:8/14/2017)... N.J. and PETACH TIKVAH, Israel ... Inc. (NASDAQ: BCLI), a leading developer of adult stem ... the second quarter ending June 30, 2017. ... stages of preparing for our pivotal Phase 3 trial ... Chaim Lebovits , President and Chief Executive Officer of ...
(Date:8/8/2017)... Second-quarter 2017 revenues of $876 million and ... operations Second-quarter 2017 Branded ... Second-quarter 2017 Sterile Injectables ... Second-quarter 2017 adjusted diluted earnings per ... $0.93 Second-quarter 2017 reported ...
Breaking Medicine Technology: